Perrigo Company plc Payments to Acquire Investments
Perrigo Company plc (PRGO) reported Payments to Acquire Investments of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2021-03-01
- Perrigo Company plc payments to acquire investments for the quarter ending 2014-09-27 was $100.00K.
- Perrigo Company plc payments to acquire investments for the quarter ending 2013-09-28 was $0.00.
- Perrigo Company plc payments to acquire investments for fiscal 2020 was $0.00.
- Perrigo Company plc payments to acquire investments for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Perrigo Company plc payments to acquire investments for fiscal 2018 was $7.50M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 12 month |
|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 | |
| 2018-12-31 | $7.50M 10-K · filed 2021-03-01 | |
| 2014-09-27 | $100.00K 8-K · filed 2014-11-20 | |
| 2013-09-28 | $0.00 8-K · filed 2014-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |